TSX:WEEDPharmaceuticals
Canopy Growth (TSX:WEED) Is Down 11.3% After U.S. Cannabis Rescheduling And Debt Cut Moves – Has The Bull Case Changed?
Earlier this month, U.S. President Donald Trump signed an executive order reclassifying cannabis from Schedule I to Schedule III, while Canopy Growth reported narrowing adjusted EBITDA losses, eliminated going‑concern warnings, and prepaid US$50 million on a senior secured term loan to cut interest costs.
At the same time, Canopy Growth advanced its Canadian footprint with an agreement to acquire Quebec-based MTL Cannabis and continued to benefit from a more supportive U.S. regulatory...